Papers on RAD51D

7 papers1 new in 30 days

Thursday, November 5

Obstetrical & Gynecological SurveyNov 5

Comment on “Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial”

Trial in 334 peopleOvarian cancer

Friday, June 19

European Journal of Breast HealthJun 19

Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines

Cross-sectional study of 8,100 peopleInterventions

Saturday, May 16

International Journal of Gynecological CancerMay 16

FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer

Study protocolReproductive system

Tuesday, November 4

American Journal of Obstetrics and GynecologyNov 4

Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution

CommentaryReproductive system

Friday, October 10

Genetics in MedicineOct 10

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

ReviewIndustry & policy

Friday, October 22

BJOGOct 22

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66

ReviewHormone replacement therapy

Thursday, October 3

Journal of Geriatric OncologyOct 3

Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis

Case-control study of 44 peopleBreast cancer